Contribution of bacterial sepsis to morbidity in infants born to HIV-infected Haitian mothers

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 3, 2006, Pages 313-319

  Noel, Francine ^a   Wright, Peter F ^b,e   Bois, Gyrlande ^a   Deschamps, Marie Marcelle ^a   De Matteis, Patricia ^a   Cassangnol, Rachelle ^a   Thimothee, Maryse ^a   Celestin, Katucia ^a   Vaz, Louise ^b   Bradshaw, John A ^c   Brignoli, Emilio ^a   Zhu, Yuwei ^b   Johnson, Warren D ^d   Fitzgerald, Daniel ^d   Pape, Jean W ^a,d  

^a Centers Institute of Infectious Diseases and Reproductive Health   (Haïti)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Cayuga Medical Center   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e D 7235 MCN ^*  (United States)

Author keywords

Bacteremia; Haiti; Pediatric HIV; Staphylococcus aureus

Indexed keywords

VIRUS RNA;

ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; HAITI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOTHER CHILD RELATION; NEWBORN; NEWBORN MORTALITY; PRIORITY JOURNAL; RNA ANALYSIS; SEPSIS; SERODIAGNOSIS; SEROLOGY; STAPHYLOCOCCUS AUREUS; VIRUS TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HAITI; HIV INFECTIONS; HUMANS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33750560231     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000242463.73817.c6     Document Type: Article

References (37)

1. Enquete de Sero-surveillance par Methode Sentinell de la Prevalence du VIH, de la Syphilis, de l'Hepatite B, et de l'Hepatite C Chez les Femmes Enceintes en Haiti 2003-2004. Port au Prince, Haiti: MSPP/IHE/GHESKIO, CDC. Juillet 2004.
2. 2004 Report on the Global HIV/AIDS Epidemic. Geneva: UNAIDS and World Health Organization. 2004. Available at http://www.unaids.org.
3. Halsey NA, Boulos R, Holt E, et al. Transmission of HIV-1 infections from mothers to infants in Haiti. Impact on childhood mortality and malnutrition. The CDS/JHU AIDS Project Team. JAMA. 1990;264:2088-2092.
4. Lucas SB, Peacock CS, Hounnou A, et al. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ. 1996;312:335-338.
5. Vetter KM, Djomand G, Zadi F, et al. Clinical spectrum of human immunodeficiency virus disease in children in a West African city. Pediatr Infect Dis J. 1996;15:438-442.
6. Spira R, Lepage P, Misellati P, et al. Natural history of human deficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Pediatrics. 1999;104:e56.
7. Zar HJ, Apolles P, Argent A, et al. The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing country. Pediatr Crit Care Med. 2001;2:108-112.
8. Ikeogu MO, Wolf B, Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child. 1997;76:124-128.
9. Jean SS, Pape JW, Veriier R-I, et al. The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J. 1999;18:58-63.
10. Jean SS, Reed GW, Verdier R-I, et al. Clinical manifestations of human immunodeficiency virus infection in Haitian children. Pediatr Infect Dis J. 1997;16:600-606.
11. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 1999;353:773-780.
12. Nduati RJG, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000;283:1167-1174.
13. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802.
14. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859-868.
15. Joint United Nations Programme on HIV/AIDS. Use of co-trimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa: recommendations and operational issues. 2000. Available at http://www.unaids. org/publications/documents/care/general/WHOUNAIDSCARE.doc.
16. CDC. 1994 Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age MMWR (prepared by Caldwell MB, Oxtoby MJ). 1994;43(RR-12):1-10.
17. Sutthent R, Gaudart N, Chokpaibulkit K, et al. p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 Infection. J Clin Microbiol. 2003;41:1016-1022.
18. Laupland KB, Church DL, Mucenski M, et al. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003;187:1452-1459.
19. Ladhani S, Konana OS, Mwarumba S, et al. Bacteraemia due to Staphylococcus aureus. Arch Dis Child. 2004;89:568-571.
20. Ayoola OO, Adeyemo AA, Osinusi K. Aetiological agents, clinical features and outcome of septicaemia in infants in Ibadan. West Afr J Med. 2003;22:30-34.
21. Mulholland EK, Ogunlesi OO, Adegbola RA, et al. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J. 1999;18:S35-S41.
22. The WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. Pediatr Infect Dis J. 1999;18:S17-S22.
23. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352:39-47.
24. Norton EB, Archibald LK, Nwanyanwu OC, et al. Clinical predictors of bloodstream infections and mortality in hospitalized Malawian children. Pediatr Infect Dis J. 2004;23:145-151.
25. Stauffer W, Fischer PR. Commentary: bacteremia in developing countries. Pediatr Infect Dis J. 2004;23:151-156.
26. Ruffini DD, Madhi SA. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS. 2002;16:105-112.
27. Graham SM, Mtitimila EI, Kamanga HS, et al. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet. 2000;355:369-373.
28. Jeena PM, Coovadia HM, Chrystal V. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr. 1997;76:124-128.
29. Madhi SA, Cutland C, Ismail K, et al. Ineffectiveness of trimethoprimsulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii Pneumonia. Clin Infect Dis. 2002;35:1120-1126.
30. Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364:1865-1871.
31. O'Brien KL, Ruff AJ, Louis MA, et al. Bacillus Calmette-Guerin complications in children born to HIV-1-infected women with a review of the literature. Pediatrics. 1995;95:414-418.
32. Edwards KM, Kernodle DS. Possible hazards of routine bacillus Calmette-Guerin immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1996;15:836-838.
33. Waddell RD, Lishimpi K, von Reyn CF, et al. Dartmouth/UCLMS/UNZA Collaborative Study Group. Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guerin (BCG) among HIV-positive children and adults in Zambia. AIDS. 2001;15:55-60.
34. Archibald LK, Kazembe PN, Nwanyanwu O, et al. Epidemiology of bloodstream infections in a bacille Calmette-Guerin-vaccinated pediatric population in Malawi. J Infect Dis. 2003;188:202-208.
35. Severe P, Leger P, Charles M, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med. 2005;353:2325-2334.
36. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis. 2005;41:1654-1661.
37. Lallemant M, Jourdain G, Le Coeur S, et al. Perinatal HIV Prevention Trial (Thailand) Investigators. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217-218.